AI: DeepSeek (deepseek-chat)

Q: {
  "clinicalNote": "<p>### Summary: <br>- **Age**: 54 years <br>- **BMI**: 36.4 (obesity) <br>- **Prior pregnancies**: G4P4, gestational diabetes in all <br>- **Presenting complaint**: Poorly controlled T2DM (HbA1c 8.2%), postprandial hyperglycemia (180–220 mg/dL), fatigue, blurred vision <br>- **Current medications**: Metformin 1000 mg BID, lisinopril 20 mg daily, atorvastatin 40 mg nightly, aspirin 81 mg daily <br>- **Social history**: Sedentary occupation, minimal exercise, carbohydrate-heavy diet <br><br>### Detailed Assessment: <br>- **Glycemic control**: Persistent postprandial hyperglycemia despite metformin adherence. <br>No hypoglycemia but reports fatigue and blurred vision. <br>Last HbA1c 8.2% (3 months ago), indicating suboptimal control. <br>- **Comorbidities**: Hypertension, hyperlipidemia, obesity. <br>No documented diabetic complications (retinopathy, neuropathy, nephropathy). <br>- **Lifestyle factors**: Sedentary, minimal exercise, carbohydrate-heavy diet with portion control challenges. <br>- **Patient concerns**: Fear of insulin therapy, desire to optimize oral medications. <br><br>### Plan: <br>1. **Glycemic control intensification**: <br>- Consider SGLT2 inhibitor (e.g., empagliflozin) or GLP-1 RA (e.g., semaglutide) for added glycemic control and weight benefits. <br>- If oral agents fail, discuss basal insulin with patient education. <br>2. **Labs**: Repeat HbA1c, renal function, fasting lipid panel. <br>3. **Lifestyle modifications**: <br>- Referral to diabetes educator and dietitian for carbohydrate management. <br>- Encourage structured exercise (150 min/week). <br>4. **Monitoring**: <br>- Continue home glucose logs (fasting + postprandial). <br>- Schedule annual diabetic eye and foot exams. <br>5. **Follow-up**: Re-evaluate in 4 weeks for medication adjustment and adherence assessment.</p>",
  "guidelines": [
    "Uptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management",
    "BJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy",
    "ESHRE - PCOS - 2023",
    "UHSussex - MP019 - Hypertension and Pre-eclampsia in Pregnancy",
    "UHS Anaemia in pregancy UHS-CG-0008-2023 (3)",
    "Uptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management",
    "UHS Anaemia in pregancy UHS-CG-0008-2023 (3)",
    "Uptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management"
  ],
  "prompt": "You are provided with the text of a clinical note from a patient encounter and a set of clinical guidelines. Your task is to:\n\n1. Cross-check the clinical note against each provided guideline.\n2. Identify areas in the clinical note that do not fully adhere to the guideline recommendations.\n3. Note any parts of the note that could be improved based on the guidelines.\n4. Return ONLY the HTML-formatted clinical note with the suggested changes.\n\nThe clinical note should be output as valid HTML.\nAny text in the clinical note that has been adjusted or needs adjustment (in light of the guidelines) should be wrapped in <i></i> tags (to display in italics).\nNext to each suggested change, provide the guideline reference in parentheses (e.g., the guideline's name or identifier).\n\nDO NOT include any explanatory text, introduction, or conclusion in your response.\nDO NOT include the complete text of each guideline in your response.\nDO NOT use markdown or code formatting in your response.\nONLY return the modified clinical note in HTML format, with no additional commentary.\n\nHere is the note text: <p>### Summary: <br>- **Age**: 54 years <br>- **BMI**: 36.4 (obesity) <br>- **Prior pregnancies**: G4P4, gestational diabetes in all <br>- **Presenting complaint**: Poorly controlled T2DM (HbA1c 8.2%), postprandial hyperglycemia (180–220 mg/dL), fatigue, blurred vision <br>- **Current medications**: Metformin 1000 mg BID, lisinopril 20 mg daily, atorvastatin 40 mg nightly, aspirin 81 mg daily <br>- **Social history**: Sedentary occupation, minimal exercise, carbohydrate-heavy diet <br><br>### Detailed Assessment: <br>- **Glycemic control**: Persistent postprandial hyperglycemia despite metformin adherence. <br>No hypoglycemia but reports fatigue and blurred vision. <br>Last HbA1c 8.2% (3 months ago), indicating suboptimal control. <br>- **Comorbidities**: Hypertension, hyperlipidemia, obesity. <br>No documented diabetic complications (retinopathy, neuropathy, nephropathy). <br>- **Lifestyle factors**: Sedentary, minimal exercise, carbohydrate-heavy diet with portion control challenges. <br>- **Patient concerns**: Fear of insulin therapy, desire to optimize oral medications. <br><br>### Plan: <br>1. **Glycemic control intensification**: <br>- Consider SGLT2 inhibitor (e.g., empagliflozin) or GLP-1 RA (e.g., semaglutide) for added glycemic control and weight benefits. <br>- If oral agents fail, discuss basal insulin with patient education. <br>2. **Labs**: Repeat HbA1c, renal function, fasting lipid panel. <br>3. **Lifestyle modifications**: <br>- Referral to diabetes educator and dietitian for carbohydrate management. <br>- Encourage structured exercise (150 min/week). <br>4. **Monitoring**: <br>- Continue home glucose logs (fasting + postprandial). <br>- Schedule annual diabetic eye and foot exams. <br>5. **Follow-up**: Re-evaluate in 4 weeks for medication adjustment and adherence assessment.</p>\nHere is each guideline with the title followed by the guideline:\nUptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management\nBJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy\nESHRE - PCOS - 2023\nUHSussex - MP019 - Hypertension and Pre-eclampsia in Pregnancy\nUHS Anaemia in pregancy UHS-CG-0008-2023 (3)\nUptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management\nUHS Anaemia in pregancy UHS-CG-0008-2023 (3)\nUptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management"
}

A: <p>### Summary: <br>- **Age**: 54 years <br>- **BMI**: 36.4 (obesity) <i>(BJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy)</i> <br>- **Prior pregnancies**: G4P4, gestational diabetes in all <br>- **Presenting complaint**: Poorly controlled T2DM (HbA1c 8.2%), postprandial hyperglycemia (180–220 mg/dL), fatigue, blurred vision <br>- **Current medications**: Metformin 1000 mg BID, lisinopril 20 mg daily, atorvastatin 40 mg nightly, aspirin 81 mg daily <br>- **Social history**: Sedentary occupation, minimal exercise, carbohydrate-heavy diet <br><br>### Detailed Assessment: <br>- **Glycemic control**: Persistent postprandial hyperglycemia despite metformin adherence. <br>No hypoglycemia but reports fatigue and blurred vision. <br>Last HbA1c 8.2% (3 months ago), indicating suboptimal control. <br>- **Comorbidities**: Hypertension, hyperlipidemia, obesity. <i>(UHSussex - MP019 - Hypertension and Pre-eclampsia in Pregnancy)</i> <br>No documented diabetic complications (retinopathy, neuropathy, nephropathy). <br>- **Lifestyle factors**: Sedentary, minimal exercise, carbohydrate-heavy diet with portion control challenges. <br>- **Patient concerns**: Fear of insulin therapy, desire to optimize oral medications. <br><br>### Plan: <br>1. **Glycemic control intensification**: <br>- Consider SGLT2 inhibitor (e.g., empagliflozin) or GLP-1 RA (e.g., semaglutide) for added glycemic control and weight benefits. <i>(Uptodate - 2025 - Preexisting and gestational diabetes - Intrapartum and postpartum glucose management)</i> <br>- If oral agents fail, discuss basal insulin with patient education. <br>2. **Labs**: Repeat HbA1c, renal function, fasting lipid panel. <br>3. **Lifestyle modifications**: <br>- Referral to diabetes educator and dietitian for carbohydrate management. <br>- Encourage structured exercise (150 min/week). <i>(BJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy)</i> <br>4. **Monitoring**: <br>- Continue home glucose logs (fasting + postprandial). <br>- Schedule annual diabetic eye and foot exams. <br>5. **Follow-up**: Re-evaluate in 4 weeks for medication adjustment and adherence assessment.</p>